Sonoma Pharmaceuticals, Inc. (SNOA) stock
SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3082% below fair value
$0.83−0.05 (-5.21%)
Close on Nov 17, 2026Market cap $3.99MP/E –Yield –
Sonoma Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Sonoma Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$2.57M. For fiscal 2026 it was -$3.93M. The highest annual figure on record is $1.15M in fiscal 2013.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$3.93M | – |
| FY2025 | Mar 31, 2025 | -$88.00K | – |
| FY2024 | Mar 31, 2024 | -$2.40M | – |
| FY2023 | Mar 31, 2023 | -$6.15M | – |
| FY2022 | Mar 31, 2022 | -$4.25M | – |
| FY2021 | Mar 31, 2021 | -$3.38M | – |
| FY2020 | Mar 31, 2020 | -$4.59M | – |
| FY2019 | Mar 31, 2019 | -$11.72M | – |
| FY2018 | Mar 31, 2018 | -$12.44M | – |
| FY2017 | Mar 31, 2017 | -$8.17M | – |
| FY2016 | Mar 31, 2016 | -$8.75M | – |
| FY2015 | Mar 31, 2015 | -$6.69M | – |
| FY2014 | Mar 31, 2014 | -$4.89M | -525.2% |
| FY2013 | Mar 31, 2013 | $1.15M | – |
| FY2012 | Mar 31, 2012 | -$4.03M | – |
| FY2011 | Mar 31, 2011 | -$4.43M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$649.00K | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$519.00K | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$764.00K | -235.2% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$635.00K | -279.4% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$2.02M | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$95.00K | -162.5% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $565.00K | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $354.00K | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$912.00K | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $152.00K | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$1.10M | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$1.23M | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$215.00K | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$2.44M | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$348.00K | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$1.83M | – |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$1.53M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$1.40M | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$326.00K | -143.7% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -$1.30M | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$1.22M | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$1.48M | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $746.00K | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$357.00K | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$2.29M | -410.4% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$3.59M | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$840.00K | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$898.00K | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $738.00K | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$2.75M | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | -$2.36M | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | -$3.55M | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$3.06M | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$3.05M | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | -$2.16M | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | -$2.60M | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | -$4.63M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | -$2.70M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | -$1.47M | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | -$1.62M | – |
See a number that looks wrong?